Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group
Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that Negma Group (“Negma”) has by notice to Mendus requested the conversion of convertible bonds that have been issued to Negma in accordance with the financing agreement announced by Mendus through press releases on 26 August and 26 October 2022.
Negma has requested conversion of eight (8) convertible bonds issued on 3 January 2023, corresponding to SEK 200,000 of the convertible loan amounting to a total of SEK 11,575,000, into 128,205 shares. Upon registration at the Swedish Companies Registration Office, Mendus’ total share capital will amount to SEK 10,030,170.60 and the total number of shares and votes will amount to 200,603,412.
The conversion price per share is SEK 1.56, equivalent to 92% of the lowest closing volume weighted average share price (VWAP) of the 10 consecutive trading days preceding the issuance of conversion request by Negma.
For further information regarding the convertible bonds issued on 3 January 2023, please refer to the press release published on 5 January 2023.
Please refer to the section “Convertible Bonds” of the Investors page at Mendus’ website for a summary of all outstanding convertible bonds and issued shares upon conversion in regard to the financing agreement with Negma.
FOR MORE INFORMATION, PLEASE CONTACT:
Chief Executive Officer
LifeSci Advisors, LLC
Telephone: + 1 212-915-2577
Telephone: +49 160 9352 9951
ABOUT MENDUS AB (PUBL)
Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST. http://www.mendus.com/
AttachmentTo view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Nexstim Abp: ordinarie bolagsstämmans beslut31.3.2023 12:00:00 CEST | Pressemelding
Företagsmeddelande, Helsingfors, 31.3.2023 kl. 13.00(EEST) Nexstim Abp: ordinarie bolagsstämmans beslut Nexstim Abp (NXTMH:HEX, NXTMS:STO) ("Nexstim" eller "Bolaget") tillkännager idag besluten från bolagsstämman som fattades den 31 mars 2023 enligt följande: 1 BEKRÄFTELSE AV BOKSLUT OCH KONCERNBOKSLUT, RÄKENSKAPSPERIODENS RESULTAT OCH BEVILJANDE AV ANSVARSFRIHET Bolagsstämman fastställde bolagets bokslut och koncernbokslut för år 2022 och beslöt att vinsten för räkenskapsperioden 1.1.-31.12.2022 bokförs på bolagets balanserad vinst- konto. Bolagsstämman beslöt att bevilja styrelsens ledamöter och verkställande direktören ansvarsfrihet för räkenskapsåret 1.1.-31.12.2022. 2 ANTAL OCH VAL AV STYRELSELEDAMÖTER, VAL AV ORDFÖRANDE Bolagsstämman beslöt i enlighet med valberedningskommitténs förslag att: • Antalet styrelseledamöter fastställs till (4); • Tero Weckroth, Timo Hildén, Martin Forss och Leena Niemistö omväljs till styrelseledamöter. • Leena Niemistö väljs till styrelsens ordförand
Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders31.3.2023 12:00:00 CEST | Press release
Company Announcement, Helsinki, 31 March 2023 at 1 PM (EEST) Nexstim Plc: Resolutions of the Annual General Meeting of Shareholders Nexstim Plc (NXTMH:HEX, NXTMS:STO) (“Nexstim” or “Company”), announces as follows regarding the resolutions that were adopted at its Annual General Meeting of Shareholders held today on 31 March 2023. 1 PRESENTATION OF THE ANNUAL ACCOUNTS AND CONSOLIDATED ACCOUNTS, PROFIT FOR THE FINANCIAL YEAR AND DISCHARGE FROM LIABILITY. The annual general meeting adopted the company’s financial statements, including the consolidated financial statements, for the year 2022 and resolved that the profit of the financial year is recorded on the accumulated profits account. The annual general meeting discharged the members of the board of directors and the managing director from liability for the financial year 1 January–31 December 2022. 2 ELECTION AND NUMBER OF THE MEMBERS, AND ELECTION OF THE CHAIRMAN OF THE BOARD OF DIRECTORS In accordance with the proposal of the nomin
Tulikivi Corporation’s annual report for 2022 has been published31.3.2023 12:00:00 CEST | Press release
TULIKIVI CORPORATION STOCK EXCHANGE RELEASE 31 MARCH 2023 AT 13:00 The Tulikivi Corporation annual report for 2022 includes the company's financial statements for 2022 and the auditors' report, the Board of Directors' report, the corporate governance statement and the remuneration report. Tulikivi Corporation has published its financial statements in the XHTML format compliant with the European Single Electronic Format (ESEF) reporting requirements. In accordance with the ESEF requirements, the main statements in the consolidated financial statements and the notes have been tagged with XBRL. The auditor has submitted a certification report on the ESEF financial statements. The financial statements are appended to this bulletin in the XHTML format and the annual report as a PDF file. The files are also available on the company's website at www.tulikivi.com. TULIKIVI CORPORATION Board of Directors Further information: Heikki Vauhkonen, Managing Director, tel. +358 (0)207 636 555 Distribu
NORBIT - NOK 270 million frame agreement received for On-Board Units31.3.2023 11:45:00 CEST | Press release
Trondheim, 31 March 2023: Today, NORBIT is pleased to announce the award of a new frame agreement for delivery of On-Board Units from an undisclosed customer. The frame agreement covers deliveries for a two-year period across 2023-2025. The contract value is estimated to be in excess NOK 270 million. “Being able to conclude this significant frame agreement confirms that our strategy of migrating our On-Board Unit business into long term partnerships remains successful. This enables us to tailor our offering and bring added value to our customers”, says Per Jørgen Weisethaunet, CEO of NORBIT. For further queries, please contact: Per Jørgen Weisethaunet, CEO, +47 959 62 915 Per Kristian Reppe, CFO, +47 900 33 203 About NORBIT ASA NORBIT is a global company providing tailored technology to selected applications by solving challenges through innovative solutions, in line with its mission to Explore More. The company is structured in three business segments to address its key markets: Ocean
Ny afdeling Balance C Akkumulerende i Investeringsforeningen PFA Invest31.3.2023 11:27:08 CEST | Press release
Investeringsforeningen PFA Invests bestyrelse har den 8. marts 2023 besluttet at oprette af en ny afdeling, Balance C Akkumulerende. Afdelingen blev godkendt af Finanstilsynet den 10. januar 2023. Vedlagt offentliggøres tegningsprospektet for afdelingen under Investeringsforeningen PFA Invest • Balance C Akkumulerende Andele i afdelingen udbydes til tegning fra den 11. april 2023 til den 24. april 2023, begge dage inklusive, og andele udbydes i tegningsperioden til tegningskurs 100,20. Tegning af min. 1 mio. kr. i afdelingen er garanteret af PFA Pension, forsikringsaktieselskab. Resultat af tegningen forventes offentliggjort den 25. april 2023. NASDAQ OMX Copenhagen A/S har godkendt at andelene optages til handel med forventet 1. handelsdag den 28. april 2023. Yderligere information kan findes på www.pfainvest.dk Med venlig hilsen PFA Asset Management A/S Attachment Tegningsprospekt PFA Invest - Balance C Akkumulerende